Clinical response to a 12 month histrelin hydrogel implant for the treatment of prostate cancer

摘要

Prostate cancer is the second leading cause of cancer death in American men. Since 1990 the incidence of this disease has almost tripled. The increase is related to the use of prostate specific antigen (PSA) testing as a screening tool and an increase in public awareness of the disease.